By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Profectus BioSciences, Inc. 

1450 South Rolling Road

Baltimore  Maryland  21227  U.S.A.
Phone: 443-543-5011 Fax: 443-543-5013



Start Up

Company News
Profectus BioSciences, Inc. Nabs $9.5 Million Government Grant 10/31/2014 7:21:14 AM
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses 10/22/2014 7:01:47 AM
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014 6:57:00 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
HHS Contracts With Profectus BioSciences, Inc. To Manufacture Ebola Vaccine For Animal Safety Studies 10/19/2014 6:56:48 PM
Profectus BioSciences, Inc. Awarded $3.5M National Institutes of Health (NIH) SBIR Grants To Advance Therapeutic Vaccines Against HIV 7/29/2014 9:19:06 AM
Profectus BioSciences, Inc. Presents Data at Filovirus Medical Countermeasures Meeting Showing That a Single Dose of VSV-Vectored Vaccine Completely Protects Monkey Against Challenge With Ebola and Marburg Viruses 9/24/2013 9:56:41 AM
Profectus BioSciences, Inc. Announces Initiation of Clinical Trial Evaluating its Therapeutic HIV Vaccine in Support of the “Cure Agenda” 9/17/2013 10:06:33 AM
Althea Technologies, Inc. & Profectus BioSciences, Inc. Sign Manufacturing Agreement for Plasmid DNA Production 2/26/2013 9:32:33 AM
Profectus BioSciences, Inc.'s Vesicular Stomatitis Virus-Vectored HIV-1 Vaccine Safe and Immunogenic in Government Sponsored Phase 1 Trial 12/4/2012 10:35:53 AM